Pacific Biosciences of California Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
Merger Arbitrage Spread Performance - Feb. 24, 2019
Article By: Malcolm Spink
Sunday, February 24, 2019 2:18 PM EDT
This is the analysis and performance review of the top 20 US based cash merger arbitrage spreads for the week 19th-22nd February. Included in this week's report are the winners, losers and overall performance of the portfolio.
In this article: NXTM, RHT, TRCO, NXST, PACB, MNA, SPY, HIFR
Read
Illumina To Acquire Pacific Biosciences For $8 Per Share
Article By: The Fly
Thursday, November 1, 2018 5:15 PM EDT
The agreement has been approved by the board of directors of Illumina and Pacific Biosciences. The acquisition complements Illumina sequencing solutions with accurate long-read sequencing capabilities to answer a set of complex genomic questions.
In this article: ILMN, PACB
Read
Pacific Biosciences Of California, Inc. Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Monday, February 12, 2018 5:44 PM EDT
Pacific Biosciences of California, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
In this article: PACB
Read
Pacific Biosciences Looks Promising As It Targets Low Competition Plant Genome Segment
Article By: KKD Healthcare Analytics
Thursday, June 29, 2017 9:51 AM EDT
Pacific Biosciences has taken several remedial steps to ensure that Sequel systems gain wider approval in the market. These steps included designing software and chemical updates for the systems.
In this article: PACB
Read
Illumina Misses Revenue Forecast Causing Collateral Damage To Biotechs
Article By: Rod Raynovich
Tuesday, October 11, 2016 11:00 PM EDT
Illumina shares crashed 25% to $139, after a warning on third quarter sales. The global leader in DNA sequencing systems warned that revenues missed forecast and would be $607M, well short of earlier guidance of $625-$630M.
In this article: TMO, RHHBY, IBB, ILMN, PACB, QGEN, XBI, XLV, FMI
Read

PARTNER HEADLINES

Latest Tweets for $PACB

No tweets yet!